Back

Predictors of recurrent ventricular arrhythmias and the impact of genetic testing in a hypertrophic cardiomyopathy patient cohort at long term follow up

13 April 2026 (12:30 - 13:15)
Organised by: Logo
Congress Presentation Part of: Arrhythmia management in patients with hypertrophic cardiomyopathy Implantable Cardioverter-Defibrillator (ICD) EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Heather Moore

Somerset NHS Foundation, Somerset nhs Foundation (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
Prognostic significance of artificial intelligence quantified late gadolinium enhancement in hypertrophic cardiomyopathy
Doctor Y. Jeong (Daegu, KR)
Abstract Slides Video
Presentation thumbnail
Defibrillation threshold testing in hypertrophic cardiomyopathy: acute outcomes and long-term follow-up
Doctor Y. Bocchini (Bad Oeynhausen, DE)
Abstract Slides Video
Presentation thumbnail
Electromechanical predictors of haemodynamic and clinical efficacy of electro-mechanically optimised RV pacing for obstructive hypertrophic cardiomyopathy: a stratified analysis of EMORI-HCM
Doctor J. Mohal (London, GB)
Abstract Slides Video
Presentation thumbnail
Long-term outcomes of catheter ablation for sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy
Doctor A. Keresteci (Ankara, TR)
Abstract Slides Video
Presentation thumbnail
Impact of phenotypic profile and genotype on ventricular tachycardia ablation outcomes in hypertrophic cardiomyopathy
Doctor A. Meretta (Leiden, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Arrhythmia management in patients with hypertrophic cardiomyopathy

The Event

Event poster

EHRA 2026

13 April 2026 12:30 CET
You may be interested in
thumbnail
Congress Presentation
Predictors of implantable cardio-defibrillator activation in patients with hypertrophic cardiomyopathy at primary prevention of sudden cardiac death
thumbnail
Congress Presentation
Long-term follow-up in patients with hypertrophic cardiomyopathy after defibrillator implantation: analysis of appropriate and inappropriate therapy
thumbnail
Congress Presentation
Revisiting risk stratification in hypertrophic cardiomyopathy after the recent guidelines - LGE remains tough to beat

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources